Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C37H70N2O12 |
Molecular Weight | 734.9579 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 18 / 18 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)O[C@H]2[C@H](C)[C@@H](O[C@]3([H])O[C@H](C)C[C@H](NC)[C@H]3O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]2C
InChI
InChIKey=FZYUKBLYECHAGN-HOQMJRDDSA-N
InChI=1S/C37H70N2O12/c1-14-26-37(10,45)30(41)23(6)39(12)18-19(2)16-35(8,44)32(51-34-28(40)25(38-11)15-20(3)47-34)21(4)29(22(5)33(43)49-26)50-27-17-36(9,46-13)31(42)24(7)48-27/h19-32,34,38,40-42,44-45H,14-18H2,1-13H3/t19-,20-,21+,22-,23-,24+,25+,26-,27+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1
Molecular Formula | C37H70N2O12 |
Molecular Weight | 734.9579 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 18 / 18 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: doi:10.11250/chemotherapy1995.43.Supplement6_110Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/1651945 | https://www.ncbi.nlm.nih.gov/pubmed/1328265
Sources: doi:10.11250/chemotherapy1995.43.Supplement6_110
Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/1651945 | https://www.ncbi.nlm.nih.gov/pubmed/1328265
N’-(desmethyl)azithromycin (CP-64434 hydrate) is the metabolite of azithromycin. Azithromycin is an effective therapeutic agent for oral treatment of sexually transmitted diseases, upper and lower respiratory tract infections, and skin and skin structure infections. 0.1 and 7.6% of azithromycin dose are excreted as N’-(desmethyl)azithromycin during a day in urine and feces, respectively. 2.9% of dose - biliary excretion.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
High-performance liquid chromatographic assay with electrochemical detection for azithromycin in serum and tissues. | 1991 Apr 19 |
|
Equivalence of a high-performance liquid chromatographic assay and a bioassay of azithromycin in human serum samples. | 1992 May 8 |
|
LC determination of impurities in azithromycin tablets. | 2003 Sep 19 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:55:06 GMT 2023
by
admin
on
Sat Dec 16 05:55:06 GMT 2023
|
Record UNII |
3E93A68ETO
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3E93A68ETO
Created by
admin on Sat Dec 16 05:55:06 GMT 2023 , Edited by admin on Sat Dec 16 05:55:06 GMT 2023
|
PRIMARY | |||
|
172617-84-4
Created by
admin on Sat Dec 16 05:55:06 GMT 2023 , Edited by admin on Sat Dec 16 05:55:06 GMT 2023
|
PRIMARY | |||
|
1046089
Created by
admin on Sat Dec 16 05:55:06 GMT 2023 , Edited by admin on Sat Dec 16 05:55:06 GMT 2023
|
PRIMARY | |||
|
DTXSID30169356
Created by
admin on Sat Dec 16 05:55:06 GMT 2023 , Edited by admin on Sat Dec 16 05:55:06 GMT 2023
|
PRIMARY | |||
|
9987533
Created by
admin on Sat Dec 16 05:55:06 GMT 2023 , Edited by admin on Sat Dec 16 05:55:06 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
For the calculation of content, multiply the peak area by 0.3
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|